EKF Diagnostics (OTCMKTS:EKDHF) Stock Rating Lowered by Investec

EKF Diagnostics (OTCMKTS:EKDHF) was downgraded by Investec from a “buy” rating to a “hold” rating in a research note issued on Friday, FlyOnTheWall reports.

EKF Diagnostics Price Performance

EKF Diagnostics stock opened at $0.31 on Friday. The firm has a 50 day simple moving average of $0.31 and a 200-day simple moving average of $0.32. EKF Diagnostics has a 1-year low of $0.31 and a 1-year high of $0.31.

About EKF Diagnostics

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.